Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Natco Pharma gets USFDA EIR for Kothur Pharma division

USFDA issues 4 observations for Zydus Jarod injectable manufacturing plant

Ruchika Sharma6 Sept 2025 11:39 AM IST

Ahmedabad: Zydus Lifesciences has announced that the U.S. Food and Drug Administration (USFDA) has issued four observations at the completion of...

Lupin Secures CDSCO Panel Nod for Phase IV Trial of Budesonide-Based COPD Inhaler

Lupin gets 2 USFDA observations for Aurangabad facility

Ruchika Sharma6 Sept 2025 11:21 AM IST

Mumbai: Lupin has received two observations from the U.S. Food and Drug Administration (USFDA) at the closure of an inspection at the Company's...

ICMR licenses nine breakthrough health technologies to industry partners including Biological E, Zydus

MD Bureau5 Sept 2025 4:59 PM IST

New Delhi: In a landmark moment for India’s healthcare innovation ecosystem, the Indian Council of Medical Research (ICMR) licensed nine cutting-edge...

Granules India, NIPER SAS Nagar inaugurate Centre of Excellence for Sustainable Pharma Innovation

Ruchika Sharma5 Sept 2025 3:30 PM IST

Mumbai: Granules India Limited, in partnership with the National Institute of Pharmaceutical Education and Research (NIPER), S.A.S Nagar, has...

DPIIT collaborate with Pfizer to strengthen India healthcare innovation ecosystem

Ruchika Sharma5 Sept 2025 2:30 PM IST

New Delhi: In a significant step towards strengthening India's healthcare innovation ecosystem, the Department for Promotion of Industry and...

ICMR, CDSCO, Industry leaders emphasize collaboration, regulatory reforms to strengthen India's pharma leadership

Ruchika Sharma5 Sept 2025 1:30 PM IST

New Delhi: Union Minister for Commerce and Industry, Shri Piyush Goyal has inaugurated the Second Edition of the India MedTech Expo 2025 at...

Zydus Lifesciences names Nitin D Parekh as President (Special Projects)

Ruchika Sharma5 Sept 2025 12:02 PM IST

Ahmedabad: Zydus Lifesciences has announced the appointment of Nitin D. Parekh as President (Special Projects), with effect from September...

Biocon Biologics, Amgen strike settlement

Biocon Biologics Bengaluru facility gets 5 USFDA observations

Ruchika Sharma5 Sept 2025 11:21 AM IST

Bengaluru: Biocon has announced that the U.S. Food and Drug Administration (FDA) has concluded a routine cGMP inspection with five observations...

Zydus Gets CDSCO Panel Nod to Market Sodium Chloride Nebuliser Solution

Zydus, Synthon enter licensing, supply agreement for multiple sclerosis drug Ozanimod for US market

Ruchika Sharma4 Sept 2025 5:56 PM IST

As one of the first filers, Synthon has received tentative approval within 30 months from USFDA.

Novartis commences tender offer to buy Tourmaline Bio

Novartis, Argo Biopharma expand strategic alliance with USD 5.2 billion Cardiovascular drugs deal

Ruchika Sharma4 Sept 2025 12:13 PM IST

Shanghai: Argo Biopharmaceutical Co., Ltd., a clinical-stage biotechnology company focused on developing next-generation siRNA therapeutics, has...

GE HealthCare Revolution Vibe CT system gets USFDA clearance

Ruchika Sharma4 Sept 2025 11:30 AM IST

Chicago: GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Revolution Vibe CT system, an...

Novartis, Arrowhead strike upto USD 2 billion deal for neuromuscular therapy license

Ruchika Sharma4 Sept 2025 10:30 AM IST

Under the terms of the agreement, Novartis will receive an exclusive worldwide license to research, develop, manufacture, and commercialize ARO-SNCA.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok